In addition, the number of injections and blood glucose monitoring can be reduced compared to MDIs, thus enhancing adherence to medication
If were working on eating disorder treatment focusing primarily on just weight loss, it does kind of go against the ethos of what were working toward. Ihlenfeld added that some small studies have found GLP-1s may help reduce binge eating behaviors
Novo Nordisk is currently running two large Phase 3 trials to investigate the effect of GLP-1 drugs on Alzheimer's disease, based on early data suggesting reduced neuroinflammation, improved cognition and function, and enhanced memory, as well as trials in which GLP-1 drugs appeared to substantially reduce dementia rates in diabetes patients
Nakhaei K, Ishijima M, Ikeda T, Ghassemi A, Saruta J, Ogawa T
But there's still only 33% household penetration, so we view that as a significant runway in this space